A Pig's Heart, a Human's Catheter: The Science of Cardiovascular Device Testing

A roughly 300-gram pig heart is more than the final hurdle before a cardiac catheter reaches the market. In recent years it has also become something surgeons transplant directly into human patients. The pig cardiovascular system is the closest available animal match to the human one in anatomy, physiology, metabolism, and immune response, which makes it the primary preclinical testbed for cardiovascular devices (Jia et al., 2024; Rusakova et al., 2024). Pigs are roughly three times more sensitive to induced ventricular fibrillation than humans, which makes catheter manipulation itself a real risk and turns external defibrillators into standard equipment rather than backup gear (Walcott et al., 2015). Pigs also spontaneously develop the same cardiovascular diseases and surgical complications seen in human patients, failing in the same ways human hearts do, which is exactly what makes the model credible. And pig hearts are now being transplanted whole into human bodies, a different undertaking from device testing, though survival after transplant remains short (Boulet et al., 2022).

Ask most people why cardiovascular devices are tested in pigs first, and the instinctive answer is "pigs are bigger, cheaper, and easier to source." That instinct is only half right. Picture a catheter still in development: it might be a stent meant to prop open a narrowed artery, or a new ablation catheter designed to treat arrhythmia. Before it ever reaches an operating room, it will almost certainly have travelled through a pig's heart first. The real reason isn't cost or convenience. A pig's cardiovascular system, in its anatomy, physiology, metabolism, and immune response, resembles a human's more closely than the laboratory mouse ever could, and that makes the animal most people associate with the dinner table the primary preclinical model for cardiovascular devices (Jia et al., 2024).

Similar on the Outside, Not Entirely on the Inside

A pig's heart weighs almost exactly what a human's does, a difference of just over ten percent (Garg et al., 2013), and the left coronary artery is nearly identical in scale, falling within the typical human range (exact figures in the comparison table below). That does not mean device engineers can simply transplant human sizing specifications onto pigs, or assume that success in a pig proves a device is correctly sized for a human. Pig atrial and ventricular volumes tend to run smaller, requiring careful, individualized assessment. Some literature notes that a systematic database of porcine aortic root morphology still doesn't exist, and that gap has previously led to device-vessel size mismatches during experiments (Rusakova et al., 2024).

Pig Heart vs. Human Heart: The Key Numbers

How closely a pig resembles a human depends entirely on which parameter you pick. Heart mass and coronary calibre are nearly interchangeable; the electrophysiology differs by a factor of three; and the venous drainage takes a different route altogether. Laid side by side, the numbers say more than "the pig is the closest available model" ever could.

Figures in this table are rounded for readability; exact values, error margins, and measurement conditions are in the references.

Heart Mass Against Body Weight: A Small Gap Is What Makes the Platform Work

"A pig heart weighs about 300 g, a human heart about 270 g" is only the absolute number (Garg et al., 2013). What actually determines whether one heart can stand in for another is how large it is relative to the body it sits in, which is to say heart mass divided by body weight. The same 300-gram heart means something entirely different inside a 60 kg body than inside a 120 kg one.

The human heart is roughly half a percent of body weight, about 4 to 5 g/kg, and in healthy adult men it weighs somewhere between two hundred and close to four hundred grams (Molina & DiMaio, 2012). In market-weight pigs, that ratio sits at roughly 3 g/kg (Zurbrigg et al., 2019). The comparative-anatomy literature adds the growth curve: a sexually mature pig's heart is about 0.5% of its body weight, falling toward 0.3% as the animal grows on, and the adult human figure corresponds most closely to young pigs in the twenty-to-thirty-kilogram range (Hill & Iaizzo, 2005).

Both species sit inside the same 0.3–0.5% band, and that gap is small enough to qualify the pig heart as a size-matched test platform. The contrast case makes it obvious: a dog's heart can reach about 7 g/kg, more than twice a similarly sized pig's (Hill & Iaizzo, 2005). A dog's heart is simply too large for its body; a pig's, like a human's, is a small fraction of it.

The gap is small but its direction is consistent: the pig's ratio runs lower, and the heavier the animal, the further it falls, because the heart does not grow in proportion to the body. So a pig heart matches a human heart not because the ratios are identical, but because picking the right body weight lands the pig's absolute heart mass inside the human range. A research pig in the twenty-to-thirty-kilogram range is closest to the adult human ratio; by market weight, the same animal still carries a heart of only around three hundred grams, a share of body weight down to about two-thirds of the human figure. This is precisely why cardiovascular device studies specify a body-weight range rather than simply specifying "pigs."

That ratio has a second use in veterinary pathology: it is itself an indicator of cardiac disease. In a study of 396 pig hearts from an Ontario abattoir, hearts with lesions had significantly higher heart-weight-to-body-weight ratios than hearts without, reflecting remodeling and hypertrophy already underway (Zurbrigg et al., 2018). The same number that confirms "this pig's heart is the right size to serve as a test platform" also screens out the hearts that are no longer normal.

The row easiest to skip is the one that shapes experimental design most. Collateral circulation is the heart's backup supply when a main vessel closes: dogs are richly collateralised, so tying off the same artery produces a far smaller infarct and results that translate poorly to patients. Pigs, like humans, have no such fallback, which makes the ischemic territory relatively predictable and is precisely why the pig became the mainstream myocardial infarction model (Maxwell et al., 1987).

One difference sits outside that table and operators still run into it: the left azygos vein. In humans it regresses during development and blood returns via the superior vena cava, while in pigs it persists and empties straight into the coronary sinus (Crick et al., 1998). Any procedure that places electrodes or leads through the coronary sinus needs its route and anatomical landmarks re-established rather than carried over from human experience.

Rhythm "Irregularities": Pigs Are More Sensitive Than Humans

Respiratory sinus arrhythmia, the heart rate speeding and slowing with breathing, is actually a normal physiological finding in both humans and pigs, a common marker of healthy vagal tone that shows up especially clearly in young, athletic individuals. It is not, as intuition might suggest, something unique to pigs. The real difference shows up under anesthesia and open-chest surgery, conditions under which a pig's autonomic nervous system reacts more sharply and its cardiac electrophysiology becomes less stable. That's precisely why pigs are used to study ventricular fibrillation (VF): direct comparative measurements show pigs are roughly three times more sensitive to electrically induced VF than humans (Walcott et al., 2015).

Back to that row in the table: the pig's induction threshold sits well below the human one, at roughly a third of it (Walcott et al., 2015). The "induction threshold" is the minimum electrical stimulus needed to knock a heart out of normal contraction and into ventricular fibrillation, a state in which it can no longer pump blood effectively. A lower threshold means the heart is easier to disrupt; a higher one means it can absorb more electrical interference before failing. A pig's VF threshold sits at roughly a third of a human's, so in practice, the same catheter applied with the same force and current might stay safely within bounds during a human procedure while crossing into VF-inducing territory in a pig's heart. That's why external defibrillators are standard equipment, not optional backup, in any lab running porcine cardiac catheter studies: the odds of triggering VF through the procedure itself are simply much higher than in a human operating room. The literature at this point mostly documents the size of that gap rather than explaining its cause; what specific physiological mechanism makes the pig heart more inducible remains an open question (Walcott et al., 2015).

A Catheter Barely Touches the Heart, and Fibrillation Follows

In the lab, that number isn't theoretical. Catheters and electrode leads have triggered ventricular fibrillation the moment they entered a pig's heart, before its sinus rhythm even had time to settle, and without a defibrillator on hand and ready, the heart cannot recover normal output on its own and the animal moves rapidly toward death. Because a pig's VF threshold sits so far below a human's, the risk of triggering a lethal rhythm during catheter manipulation is inherently higher than in a human procedure, which is exactly why an external defibrillator is standard equipment in any porcine cardiac catheter lab, not a contingency.

Pigs Get Heart Disease Too, Not Just a Body of the Right Size

Pigs spontaneously develop atherosclerosis and are prone to sudden cardiac death (Jia et al., 2024). That matters because it means a pig is not simply a convenient-sized stand-in for surgical practice; its disease pathology genuinely mirrors human disease. This is something no mouse model can offer, since laboratory mice almost never develop the cardiovascular disease seen in humans on their own, forcing researchers to induce it artificially through genetic engineering or pharmacological manipulation. A pig's spontaneous disease pattern lets researchers observe a disease course that tracks much closer to real clinical reality.

Even the Complications Match, and That's the Point

When pigs undergo valve-replacement surgery, they develop the same complications seen in human patients: paravalvular leak, coronary artery obstruction (Rusakova et al., 2024). That sounds like bad news, but from a research-design standpoint it's actually reassuring. If an animal model fails in the same ways human patients do, its predictive power for clinical outcomes is credible. That's also why pulsed field ablation (PFA) has been the fastest-growing subfield in the 2024–2025 literature: recent studies have measured, in chronic pig models, how contact forces ranging from 5 to 35 grams affect lesion size and the durability of conduction block a month later (Hua et al., 2024; Kueffer et al., 2025), turning "how hard should the catheter press" from an operator's intuition into a quantifiable, verifiable data point.

From Device Testing to Whole-Heart Transplants

Pig hearts aren't just used to test stents and catheters. In recent years they've also started serving as the transplant organ itself, a field called xenotransplantation: an entire, genetically edited pig heart transplanted into a human body (Boulet et al., 2022). From the first living human recipient of a pig heart in 2022 to gene-editing counts climbing from 10 to 69 and formal entry into FDA-regulated clinical trials, the recent progress in this field is covered in a companion piece, From One Pig Heart to 69 Gene Edits: Four Years of Xenotransplantation Progress.

Taiwan already has relevant animal-research infrastructure: Academia Sinica's Institute of Biomedical Sciences operates a core facility for cardiovascular and pre-stroke clinical animal trials, and MacKay Memorial Hospital's animal research center maintains a cardiac catheterization animal lab (both source pages were blocked by anti-crawling measures during literature review, so their current status is best confirmed against each institution's own announcements).

From a heart that weighs almost exactly what a human's does, to a disease model that reproduces the same complications, to the whole-organ transplants now being attempted, the role pigs play in cardiovascular medicine is more precise and more consequential than the phrase "animal testing" suggests. Pigs are worth studying not because they resemble us physically, but because they get sick the way we do, and recover the way we do too, and that is the invisible, months-long groundwork behind every cardiac catheter procedure.

Frequently Asked Questions

Why are cardiac catheter devices tested in pigs first?

Because a pig's cardiovascular system, in its anatomy, physiology, metabolism, and immune response, is closer to a human's than the laboratory mouse, making pigs the primary preclinical animal model for cardiovascular device testing (Jia et al., 2024).

Is a pig's heart the same size as a human's?

Very close in weight: the human heart averages about 270 grams, a pig's about 300 grams, and the left coronary artery diameter falls within the typical human range as well (Garg et al., 2013). However, pig atrial and ventricular volumes tend to run smaller, so device sizing cannot be copied directly from human specifications (Rusakova et al., 2024).

Is a pig's heart the same share of body weight as a human's?

Close, but not identical. The human heart is about half a percent of body weight, roughly 4 to 5 g/kg (Molina & DiMaio, 2012), while market-weight pigs sit at about 3 g/kg (Zurbrigg et al., 2019) — both inside the same 0.3–0.5% band. A dog, by comparison, reaches about 7 g/kg, more than double a pig's (Hill & Iaizzo, 2005). That small gap is what allows a pig heart to serve as a size-matched test platform, but because the pig's ratio falls as the animal grows, studies have to specify a body-weight range rather than simply specifying "pigs."

Why can't cardiovascular devices just be tested in mice?

Mice almost never develop the cardiovascular disease common in humans on their own; researchers have to induce it through genetic engineering or drugs. Pigs spontaneously develop atherosclerosis, so their disease pathology genuinely resembles human disease, letting researchers observe a course of disease much closer to real clinical reality (Jia et al., 2024).

Are pigs as sensitive to arrhythmia as humans?

Not exactly. Respiratory sinus arrhythmia is a normal physiological finding in both humans and pigs, but under anesthesia and open-chest surgery a pig's autonomic nervous system reacts more sharply. The literature also shows pigs are roughly three times more sensitive to electrically induced ventricular fibrillation than humans (Walcott et al., 2015).

Why does cardiac catheterization carry a risk of ventricular fibrillation in pigs?

Because a pig's threshold for inducing ventricular fibrillation is much lower than a human's — roughly a third of it (Walcott et al., 2015) — simply placing a catheter or electrode lead in the heart carries an inherent risk of triggering it. Fibrillation has been triggered in the lab the moment a catheter entered the heart, which is why external defibrillators are standard equipment.

What complications occur during pig heart valve-replacement surgery?

Pigs develop the same complications seen in human patients, including paravalvular leak and coronary artery obstruction (Rusakova et al., 2024). Failing in the same ways human patients do is what makes the model's predictive power for clinical outcomes credible.

Is there porcine cardiac research happening in Taiwan?

Academia Sinica's Institute of Biomedical Sciences operates a core facility for cardiovascular and pre-stroke clinical animal trials, and MacKay Memorial Hospital's animal research center maintains a cardiac catheterization animal lab.

References

Boulet, J., Cunningham, J. W., & Mehra, M. R. (2022). Cardiac xenotransplantation: Challenges, evolution, and advances. JACC: Basic to Translational Science, 7(7), 716–729. https://doi.org/10.1016/j.jacbts.2022.05.003

CNN. (2023, October 31). Second person to receive experimental pig heart transplant dies nearly six weeks after procedure. https://www.cnn.com/2023/10/31/health/lawrence-faucette-second-pig-heart-transplant-dies

Crick, S. J., Sheppard, M. N., Ho, S. Y., Gebstein, L., & Anderson, R. H. (1998). Anatomy of the pig heart: Comparisons with normal human cardiac structure. Journal of Anatomy, 193(1), 105–119. https://doi.org/10.1046/j.1469-7580.1998.19310105.x

Garg, S., Singh, P., Sharma, A., & Gupta, G. (2013). A gross comparative anatomical study of hearts in human cadavers and pigs. International Journal of Medical and Dental Sciences, 2(2), 138–143. https://ijmds.org/index.php/ijmds/article/view/566

Gómez, F. A., & Ballesteros, L. E. (2015). Evaluation of coronary dominance in pigs: A comparative study with findings in human hearts. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 67(3), 783–789. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352015000300783

Hill, A. J., & Iaizzo, P. A. (2005). Comparative cardiac anatomy. In P. A. Iaizzo (Ed.), Handbook of cardiac anatomy, physiology, and devices (pp. 87–108). Humana Press. https://doi.org/10.1007/978-1-59259-835-9_5

Hua, J., Xiong, Q., Kong, Q., Xiong, L., Huang, Q., Hu, J., Li, J., Hu, J., Si, P., Zhou, T., & Chen, Q. (2024). A novel contact force sensing pulsed field ablation catheter in a porcine model. Clinical Cardiology, 47(1), Article e24220. https://doi.org/10.1002/clc.24220

Jia, H., Chang, Y., & Song, J. (2024). The pig as an optimal animal model for cardiovascular research. Lab Animal, 53, 136–147. https://doi.org/10.1038/s41684-024-01377-4

Kueffer, T., Casoni, D., Goepfert, C., Beslac, O., Parodi, C., Ramirez, D., Garrott, K., Koop, B., Coe, S., Hagstrom, N., Gibert, G., Roten, L., Haeberlin, A., & Reichlin, T. (2025). Dose-dependent ventricular lesion formation using a novel large-area pulsed field ablation catheter: A preclinical feasibility study. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2025.02.017

Maxwell, M. P., Hearse, D. J., & Yellon, D. M. (1987). Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovascular Research, 21(10), 737–746. https://doi.org/10.1093/cvr/21.10.737

Miyagi, C., Suresh, K. S., Guo, M., & Onohara, D. (2026). Translational strategies for developing and evaluating transcatheter devices in swine heart failure models. Annals of Biomedical Engineering, 54, 1237–1257. https://doi.org/10.1007/s10439-025-03960-3

Molina, D. K., & DiMaio, V. J. M. (2012). Normal organ weights in men: Part I—The heart. The American Journal of Forensic Medicine and Pathology, 33(4), 362–367. https://doi.org/10.1097/PAF.0b013e31823d298b

NBC News. (2022, July 8). First man to receive a transplanted pig heart died of heart failure, not rejection, encouraging doctors. https://www.nbcnews.com/health/heart-health/first-man-receive-transplanted-pig-heart-died-heart-failure-not-reject-rcna37078

Paslawska, U., Noszczyk-Nowak, A., Paslawski, R., Janiszewski, A., Kiczak, L., Zysko, D., Nicpon, J., Jankowska, E. A., Szuba, A., & Ponikowski, P. (2014). Normal electrocardiographic and echocardiographic (M-mode and two-dimensional) values in Polish Landrace pigs. Acta Veterinaria Scandinavica, 56, Article 54. https://doi.org/10.1186/s13028-014-0054-2

Rusakova, Y. L., Grankin, D. S., Podolskaya, K. S., & Zhuravleva, I. Y. (2024). Pigs as models to test cardiovascular devices. Biomedicines, 12(6), Article 1245. https://doi.org/10.3390/biomedicines12061245

STAT. (2025, February 3). FDA approves first xenotransplantation clinical trial, as United Therapeutics forges ahead. https://www.statnews.com/2025/02/03/united-therapeutics-xenotransplantation-clinical-trial/

Walcott, G. P., Kroll, M. W., & Ideker, R. E. (2015). Ventricular fibrillation: Are swine a sensitive species? Journal of Interventional Cardiac Electrophysiology, 42(2), 83–89. https://doi.org/10.1007/s10840-014-9964-1

Zurbrigg, K., van Dreumel, T., Rothschild, M. F., Alves, D., Friendship, R., & O'Sullivan, T. L. (2018). Cardiac weights and weight ratios as indicators of cardiac lesions in pigs: A study of pig hearts from an Ontario abattoir. Canadian Journal of Veterinary Research, 82(3), 198–202. https://pmc.ncbi.nlm.nih.gov/articles/PMC6040014/

Zurbrigg, K., van Dreumel, T., Rothschild, M. F., Alves, D., Friendship, R. M., & O'Sullivan, T. L. (2019). Rapid communication: A comparison of cardiac lesions and heart weights from market pigs that did and did not die during transport to one Ontario abattoir. Translational Animal Science, 3(1), 149–154. https://doi.org/10.1093/tas/txy124